Sign in Welcome! Log into your account your username your password Forgot your password? Get help Privacy Policy Password recovery Recover your password your email A password will be e-mailed to you. The Scientific Evidence That Wearing a Mask Is Ineffective Harmful & Useless! Part 3 CommentaryData analysesResource April 9, 2022 Share Telegram WhatsApp Facebook Twitter https://www.drrobertyoung.com/post/the-scientific-evidence-that-wearing-masks-are-ineffective-useless-part-3?utm_campaign=ebd676e9-4181-4332-8575-2dde166215af&utm_source=so&utm_medium=mail&cid=4f5c9b00-f3cd-4892-b034-30340686d56dhttps://www.drrobertyoung.com/post/the-scientific-evidence-that-wearing-masks-are-ineffective-useless-part-3?utm_campaign=ebd676e9-4181-4332-8575-2dde166215af&utm_source=so&utm_medium=mail&cid=4f5c9b00-f3cd-4892-b034-30340686d56d Ludwig Van Search Latest articles Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination March 25, 2023 Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line March 17, 2023 Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose March 15, 2023 COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review March 15, 2023 Previous articleAs I have said before, COVID is done and OMICRON is/was the exit off-ramp; it will be ‘NOT DONE’ if this non-sterilizing injection continues; it is causing the variants every 2 mths or so; STOP vax!Next articleSpace Aliens (from Clif High) Related articles Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination Resource March 25, 2023 Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line Resource March 17, 2023 Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose Resource March 15, 2023 Leave a reply Cancel replyLog in to leave a comment
